OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 27 citing articles:

Exploring the Frontiers of Neuroimaging: A Review of Recent Advances in Understanding Brain Functioning and Disorders
Chiahui Yen, Chia-Li Lin, Ming‐Chang Chiang
Life (2023) Vol. 13, Iss. 7, pp. 1472-1472
Open Access | Times Cited: 109

Quantification of amyloid PET for future clinical use: a state-of-the-art review
Hugh Pemberton, Lyduine E. Collij, Fiona Heeman, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 10, pp. 3508-3528
Open Access | Times Cited: 106

Statistical Learning Methods for Neuroimaging Data Analysis with Applications
Hongtu Zhu, Tengfei Li, Bingxin Zhao
Annual Review of Biomedical Data Science (2023) Vol. 6, Iss. 1, pp. 73-104
Open Access | Times Cited: 19

Advanced Magnetic Resonance Imaging for Early Diagnosis and Monitoring of Movement Disorders
Emmanuel Ortega-Robles, Benito de Celis Alonso, Jessica Cantillo-Negrete, et al.
Brain Sciences (2025) Vol. 15, Iss. 1, pp. 79-79
Open Access

Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's disease
David M. Cash, Katy E. Morgan, Antoinette O’Connor, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100133-100133
Open Access

Neuroimaging to Facilitate Clinical Trials in Huntington’s Disease: Current Opinion from the EHDN Imaging Working Group
Nicola Z. Hobbs, Marina Papoutsi, Aline Delva, et al.
Journal of Huntington s Disease (2024) Vol. 13, Iss. 2, pp. 163-199
Open Access | Times Cited: 3

PET as a Translational Tool in Drug Development for Neuroscience Compounds
Andrea Varrone, Christoffer Bundgaard, Benny Bang‐Andersen
Clinical Pharmacology & Therapeutics (2022) Vol. 111, Iss. 4, pp. 774-785
Open Access | Times Cited: 13

A natural history study to track brain and spinal cord changes in individuals with Friedreich’s ataxia: TRACK-FA study protocol
Nellie Georgiou‐Karistianis, Louise A. Corben, Kathrin Reetz, et al.
PLoS ONE (2022) Vol. 17, Iss. 11, pp. e0269649-e0269649
Open Access | Times Cited: 11

Consistency between Treatment Effects on Clinical and Brain Atrophy Outcomes in Alzheimer’s Disease Trials
Mara ten Kate, Frederik Barkhof, Adam J. Schwarz
The Journal of Prevention of Alzheimer s Disease (2023)
Open Access | Times Cited: 6

Empowering drug development: Leveraging insights from imaging technologies to enable the advancement of digital health technologies
Elena S. Izmailova, R. P. Maguire, Timothy J. McCarthy, et al.
Clinical and Translational Science (2022) Vol. 16, Iss. 3, pp. 383-397
Open Access | Times Cited: 10

MR Imaging in Ataxias: Consensus Recommendations by the Ataxia Global Initiative Working Group on MRI Biomarkers
Gülin Öz, Sirio Cocozza, Pierre‐Gilles Henry, et al.
The Cerebellum (2023) Vol. 23, Iss. 3, pp. 931-945
Open Access | Times Cited: 5

Neuroimaging Advances in Neurologic and Neurodegenerative Diseases
Shannon L. Risacher, Andrew J. Saykin
Neurotherapeutics (2021) Vol. 18, Iss. 2, pp. 659-660
Open Access | Times Cited: 11

Technological Evolution in the Instrumentation of Ataxia Severity Measurement
Thang Ngo, Pubudu N. Pathirana, Malcolm Horne, et al.
IEEE Access (2023) Vol. 11, pp. 14006-14027
Open Access | Times Cited: 4

Transforming Neurology Care Delivery Through a Population Health Data Strategy
Ines M. Vigil, Martha L. Sylvia
Neurology Clinical Practice (2024) Vol. 14, Iss. 2
Closed Access | Times Cited: 1

Nanodevices in neurological infections: an update
Yangala Sudheer Babu, Neetu Kumari, Mulaka Maruthi
Elsevier eBooks (2024), pp. 51-67
Closed Access | Times Cited: 1

Prognostic enrichment for early-stage Huntington’s disease: An explainable machine learning approach for clinical trial
Mohsen Ghofrani-Jahromi, Govinda Poudel, Adeel Razi, et al.
NeuroImage Clinical (2024) Vol. 43, pp. 103650-103650
Open Access | Times Cited: 1

Recommendations to Optimize the Use of Volumetric MRI in Huntington's Disease Clinical Trials
Kirsi M. Kinnunen, Ariana P. Mullin, Dorian Pustina, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 7

A bibliometric analysis of international publication trends in brain atrophy research (2008–2023)
Ju-Wei Wang, Tingting Chen, Jiayi Xie, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access

Pathological and neurochemical correlates of locus coeruleus functional network activity
Jourdan H. Parent, Kaitlin Cassady, William J. Jagust, et al.
Biological Psychology (2024) Vol. 192, pp. 108847-108847
Open Access

Brain white matter damage biomarkers
Fardin Nabizadeh
Advances in clinical chemistry (2024), pp. 55-91
Closed Access

Dynamic evolution of brain structural patterns in liver transplantation recipients: a longitudinal study based on 3D convolutional neuronal network model
Yue Cheng, Xiaodong Zhang, Cheng Chen, et al.
European Radiology (2023) Vol. 33, Iss. 9, pp. 6134-6144
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top